Quantification of Mitral Regurgitation Using 4D MRI Flow : Comparison With 2D MRI Flow and Echocardiography Using the Evolution of Left Ventricular Remodeling as a Reference
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 160 people, planned
- Started
- 1 Oct 2025
- Expected to end
- 30 Apr 2028
- Type of study
- Interventional, 3 groups
- Treatments tested
- Standard echocardiography
- 2D phase-contrast magnetic resonance imaging
- 4D flow magnetic resonance imaging
- Cardiac ultrafast ultrasound imaging
- Record updated
- 15 July 2025
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- from 18 to 85 years old
- having signed a consent form to participate in the study
- suffering from mild, moderate or severe mitral regurgitation based on an ultrasound graduation
- able to undergo echocardiography and IRM within 7 days after recruitment and then at 6 months
Who cannot take part
- suffering from renal disease with an eGFR CKD-EPI < 30 ml/min
- suffering from aortic regurgitation or stenosis or mitral stenosis associated with more than moderate MR, intracardiac shunting or hypertrophic cardiomyopathy
- suffering from secondary MR
- having a contraindication to gadolinium-based contrast agent
- having a pacemaker, defibrillator or any other contraindication to MRI
- pregnant or breastfeeding
- under legal protection; Enrolled subjects:
- with an incomplete or suboptimal ultrasound or MRI examination
- who have not attended to the 6-month follow-up visit
- with an intercurrent medical event; will be excluded
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this study is to evaluate whether 4D MRI provides a better assessment of mitral regurgitation quantification and associated ventricular remodeling than standard imaging techniques: echocardiography and 2D MRI, in patients suffuring from mitral regurgitation. 4D MRI demonstrated its superiority to 2D MRI in some other valve diseases but remains not widely used, due to a lack of evidence. The main question our study aims to answer is:
Read full original descriptionShow less
• Is mitral regurgitant volume measured on 4D MRI more strongly related to remodeling progression (after correction of regurgitation or not) than regurgitant volume measured on 2D MRI and echocardiography?
Participants will undergo 4D MRI, 2D MRI and echocardiography twice at six-month intervals.
The 3 groups in the trial
- Mild mitral regurgitationTreatment being tested
Patient suffuring from mild mitral regurgitation (n=30)
Treatment: Standard echocardiography, 2D phase-contrast magnetic resonance imaging, 4D flow magnetic resonance imaging, and Cardiac ultrafast ultrasound imaging
- Moderate mitral regurgitationTreatment being tested
Patient suffuring from moderate mitral regurgitation (n=30)
Treatment: Standard echocardiography, 2D phase-contrast magnetic resonance imaging, 4D flow magnetic resonance imaging, and Cardiac ultrafast ultrasound imaging
- Severe mitral regurgitationTreatment being tested
Patient suffuring from severe mitral regurgitation (n=100)
Treatment: Standard echocardiography, 2D phase-contrast magnetic resonance imaging, 4D flow magnetic resonance imaging, and Cardiac ultrafast ultrasound imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07066904, who can take part
- Record updated
- 15 July 2025